AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 61 filers reported holding AC IMMUNE SA in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $3,000 | -50.0% | 760 | -61.8% | 0.00% | – |
Q1 2024 | $6,000 | -91.2% | 1,987 | -85.2% | 0.00% | – |
Q4 2023 | $68,000 | +750.0% | 13,424 | +383.4% | 0.00% | – |
Q3 2023 | $8,000 | -20.0% | 2,777 | -15.8% | 0.00% | – |
Q2 2023 | $10,000 | +233.3% | 3,299 | +179.6% | 0.00% | – |
Q1 2023 | $3,000 | +50.0% | 1,180 | 0.0% | 0.00% | – |
Q4 2022 | $2,000 | -33.3% | 1,180 | +18.0% | 0.00% | – |
Q3 2022 | $3,000 | -82.4% | 1,000 | -78.3% | 0.00% | – |
Q2 2022 | $17,000 | -37.0% | 4,600 | -32.4% | 0.00% | – |
Q1 2022 | $27,000 | -56.5% | 6,800 | -46.3% | 0.00% | – |
Q4 2021 | $62,000 | -38.0% | 12,659 | -15.0% | 0.00% | – |
Q3 2021 | $100,000 | -16.0% | 14,898 | -0.7% | 0.00% | – |
Q2 2021 | $119,000 | -39.0% | 15,004 | -41.4% | 0.00% | – |
Q1 2021 | $195,000 | +4775.0% | 25,583 | +2711.3% | 0.00% | – |
Q4 2020 | $4,000 | +300.0% | 910 | +381.5% | 0.00% | – |
Q3 2020 | $1,000 | -50.0% | 189 | -61.5% | 0.00% | – |
Q3 2019 | $2,000 | +100.0% | 491 | +94.1% | 0.00% | – |
Q2 2019 | $1,000 | -50.0% | 253 | -41.2% | 0.00% | – |
Q1 2019 | $2,000 | – | 430 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 7,062,379 | $34,959,000 | 1.27% |
Metatron Capital SICAV plc | 44,000 | $217,800,000 | 0.21% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,062,462 | $5,259,000 | 0.15% |
Artal Group S.A. | 1,000,000 | $4,950,000 | 0.13% |
EcoR1 Capital, LLC | 749,585 | $3,710,000 | 0.12% |
Lombard Odier Asset Management (Switzerland) SA | 348,196 | $1,724,000 | 0.11% |
Virtus ETF Advisers LLC | 32,852 | $163,000 | 0.06% |
Eversept Partners, LP | 153,380 | $759,231 | 0.05% |
GSA CAPITAL PARTNERS LLP | 73,046 | $362,000 | 0.04% |
COHEN LAWRENCE B | 12,850 | $64,000 | 0.02% |